Home > Quotes > SGYP

Synergy Pharmaceuticals, Inc. Common Stock (DE) Quote & Summary Data

Get SGYP Alerts
*Delayed - data as of Apr. 29, 2016  -  Find a broker to begin trading SGYP now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Synergy Pharmaceuticals, Inc. Common Stock (DE) Intraday Chart

Shares Traded

Trading Range

Intraday Last 52 Weeks
High $ 3.35 $ 10.15
Low $ 3.01 $ 2.50

The current last sale of $3.14 is 25.60% Higher thanthe 52 week low.

P/E Ratio

Company Description (as filed with the SEC)

Unless the context requires otherwise, the words "Synergy," "the Company," "we," "us," refer to Synergy Pharmaceuticals Inc. and Subsidiaries. Business Overview We are a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies. Our proprietary GI platform includes two lead product candidates -- plecanatide and dolcanatide. Since the company's inception in 2008, we have pioneered discovery, research and development efforts involving uroguanylin analogs for the treatment of functional gastrointestinal (GI) disorders and inflammatory bowel disease. Plecanatide is our first uroguanylin analog currently being evaluated for use as a once-daily tablet for two functional GI disorders, chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C). Plecanatide is a 16-amino acid peptide that is structurally identical to uroguanylin with the exception of a single amino acid change.  ... More ...  

Risk Grade

Where does SGYP fit in the risk graph?

Risk Grade Scale

Nasdaq Official Price

Consensus Recommendation

Research Brokers before you trade

Want to trade FX?